The Ohio State University Wexner Medical Center
Pathology residency · Columbus, OH · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is The Ohio State University Wexner Medical Center's research in pathology, which the program shares with other departments and affiliated hospitals.
About The Ohio State University Wexner Medical Centerinstitution-wide pathology research
Pathology publications from The Ohio State University Wexner Medical Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
75
works per year
16th of 65 pathology residency programs
-18.7%
2-year growth
58th of 65 pathology residency programs
24.9%
in top 10% of field (works before 2025)
10th of 56 pathology residency programs
47.6%
cited above world average
11th of 56 pathology residency programs
Works per year · * 2026 so far
Pathology and Forensic Medicine · 359
Pathology research topics at The Ohio State University Wexner Medical Center
Papers in the window; each links to the list on OpenAlex.
Most cited at The Ohio State University Wexner Medical Center since 2024
All pathology papers there on OpenAlex
- Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In OncologyRachel Hodan et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 126
- Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne Haney Cross et al. · JAMA Neurology · 2024 · PubMed · cited 107
- Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancerRuhina Shirin Laskar et al. · Annals of Oncology · 2024 · PubMed · cited 83
- Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort studyAyse B. Ercan et al. · The Lancet Oncology · 2024 · PubMed · cited 79
- Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).Frank A. Sinicrope et al. · Journal of Clinical Oncology · 2025 · cited 59
- Microglia promote maladaptive plasticity in autonomic circuitry after spinal cord injury in miceFaith H. Brennan et al. · Science Translational Medicine · 2024 · PubMed · cited 56
- Early management of adult traumatic spinal cord injury in patients with polytrauma: a consensus and clinical recommendations jointly developed by the World Society of Emergency Surgery (WSES) & the European Association of Neurosurgical Societies (EANS)Edoardo Picetti et al. · World Journal of Emergency Surgery · 2024 · PubMed · cited 55
- Prognostic value of tissue bridges in cervical spinal cord injury: a longitudinal, multicentre, retrospective cohort studyDario Pfyffer et al. · The Lancet Neurology · 2024 · PubMed · cited 44
- Advancing multiple sclerosis management in older adultsAnneke van der Walt et al. · Nature Reviews Neurology · 2025 · PubMed · cited 40
- Glucarpidase for treatment of high-dose methotrexate toxicityShruti Gupta et al. · Blood · 2025 · PubMed · cited 37